Drug profile · INN
tenofovir disoproxil + emtricitabine
CIPLA TENOFOVIR + EMTRICITABINE 300/200
- Patents linked
- 0
- News articles
- 0
Quick answer
tenofovir disoproxil + emtricitabine (CIPLA TENOFOVIR + EMTRICITABINE 300/200) is an FDA-listed pharmaceutical active ingredient. Associated with Cipla Australia Pty Ltd.
Key facts
INN tenofovir disoproxil + emtricitabine
Brand CIPLA TENOFOVIR + EMTRICITABINE 300/200
Originator Cipla Australia Pty Ltd
Frequently asked questions
What is tenofovir disoproxil + emtricitabine?
tenofovir disoproxil + emtricitabine (CIPLA TENOFOVIR + EMTRICITABINE 300/200) is an FDA-listed pharmaceutical active ingredient. Associated with Cipla Australia Pty Ltd.
What is the brand name for tenofovir disoproxil + emtricitabine?
CIPLA TENOFOVIR + EMTRICITABINE 300/200 is a marketed brand name for tenofovir disoproxil + emtricitabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.